Czaya B, Faul C.
The role of fibroblast growth factor 23 in inflammation and anemia.
Int J Mol Sci. 2019, 20: E4195.
Richter B, Faul C.
FGF23 actions on target tissues – with and without klotho.
Front Endocrinol 2018, 9: 189.
Grabner A, Mazzaferro S, Cianciolo G, Krick S, Capelli I, Rotondi S, Ronco C, La Manna G, Faul C.
Fibroblast growth factor 23: mineral metabolism and beyond.
Contrib Nephrol 2017, 190: 83-95.
Faul C.
Cardiac actions of fibroblast growth factor 23.
Bone 2016, 100: 69-79.
Grabner A, Faul C.
The role of FGF23 and klotho in uremic cardiomyopathy.
Curr Opin Nephrol Hypertens. 2016, 25: 314-24.
Reiser J, Sever S, Faul C.
Signal transduction in podocytes – spot light on receptor tyrosine kinases.
Nat Rev Nephrol. 2014, 10: 104-15.
Faul C.
Fibroblast growth factor 23 and the heart.
Curr Opin Nephrol Hypertens. 2012, 21: 369-75.
Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P.
Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton.
Trends Cell Biol. 2007, 17: 428-37.
Reiser J, von Gersdorff G, Simons M, Schwarz K, Faul C, Giardino L, Heider T, Loos M, Mundel P.
Novel concepts in understanding and management of glomerular proteinuria.
Nephrol Dial Transplant. 2002, 17: 951-5.
